Skip Nav Destination
Issues
Clinical Care/Education/Nutrition
PRESERVE-β: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin
Diabetes Care September 2005, Vol.28, 2093-2099. doi:https://doi.org/10.2337/diacare.28.9.2093
Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes
Thomas Danne, MD; Reinhard H. A. Becker, MD; Tim Heise, MD; Claudia Bittner, MD; Annke D. Frick, PHD; Klaus Rave, MD
Diabetes Care September 2005, Vol.28, 2100-2105. doi:https://doi.org/10.2337/diacare.28.9.2100
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : A randomized, double-masked, cross-over study
Kasper Rossing, MD; Katrine J. Schjoedt, MD; Ulla M. Smidt; Frans Boomsma, PHD; Hans-Henrik Parving, MD, DMSC
Diabetes Care September 2005, Vol.28, 2106-2112. doi:https://doi.org/10.2337/diacare.28.9.2106
The Effectiveness of β-Blockers After Myocardial Infarction in Patients With Type 2 Diabetes
Charlotte G. McDonald, MD, MSC, FRCPC; Sumit R. Majumdar, MD, MPH, FRCPC; Jeffrey L. Mahon, MD, MSC, FRCPC; Jeffrey A. Johnson, PHD
Diabetes Care September 2005, Vol.28, 2113-2117. doi:https://doi.org/10.2337/diacare.28.9.2113
Gestational Weight Gain and Pregnancy Outcomes in 481 Obese Glucose-Tolerant Women
Dorte M. Jensen, PHD; Per Ovesen, DMSC; Henning Beck-Nielsen, DMSC; Lars Mølsted-Pedersen, DMSC; Bente Sørensen, MD; Christina Vinter, MD; Peter Damm, DMSC
Diabetes Care September 2005, Vol.28, 2118-2122. doi:https://doi.org/10.2337/diacare.28.9.2118
Influence of Glycemic Index/Load on Glycemic Response, Appetite, and Food Intake in Healthy Humans
Diabetes Care September 2005, Vol.28, 2123-2129. doi:https://doi.org/10.2337/diacare.28.9.2123
Reduction of Plantar Pressure Using a Prototype Pressure-Relieving Dressing
Diabetes Care September 2005, Vol.28, 2236-2237. doi:https://doi.org/10.2337/diacare.28.9.2236
Glucose-Lowering Effects of Sulfasalazine in Type 2 Diabetes
Diabetes Care September 2005, Vol.28, 2238-2239. doi:https://doi.org/10.2337/diacare.28.9.2238
Dietary Fiber and Glucose Tolerance in Japanese Brazilians
Daniela Saes Sartorelli; Renata Damião Freire; Sandra Roberta Gouveia Ferreira; Marly Augusto Cardoso; for the Japanese-Brazilian Diabetes Study Group
Diabetes Care September 2005, Vol.28, 2240-2242. doi:https://doi.org/10.2337/diacare.28.9.2240
Epidemiology/Health Services/Psychosocial Research
The Burden of Mortality Attributable to Diabetes : Realistic estimates for the year 2000
Gojka Roglic, MD; Nigel Unwin, DM, MFPH; Peter H. Bennett, MB, FRCP; Colin Mathers, BSC, PHD; Jaakko Tuomilehto, MD, PHD; Satyajit Nag, MRCP; Vincent Connolly, MD, FRCP; Hilary King, MD, DSC
Diabetes Care September 2005, Vol.28, 2130-2135. doi:https://doi.org/10.2337/diacare.28.9.2130
Access to Care for Patients With Insulin-Requiring Diabetes in Developing Countries: Case studies of Mozambique and Zambia
Diabetes Care September 2005, Vol.28, 2136-2140. doi:https://doi.org/10.2337/diacare.28.9.2136
Diabetes Is Associated With Dramatically Decreased Survival in Female but Not Male Subjects With Cystic Fibrosis
Diabetes Care September 2005, Vol.28, 2141-2144. doi:https://doi.org/10.2337/diacare.28.9.2141
Biofeedback-Assisted Relaxation in Type 2 Diabetes
Ronald A. McGinnis, MD; Angele McGrady, PHD, MED, LPCC; Stephen A. Cox, MD; Kimber A. Grower-Dowling, BA
Diabetes Care September 2005, Vol.28, 2145-2149. doi:https://doi.org/10.2337/diacare.28.9.2145
The Impact of Psychiatric Comorbidities on Readmissions for Diabetes in Youth
Diabetes Care September 2005, Vol.28, 2150-2154. doi:https://doi.org/10.2337/diacare.28.9.2150
Risking Health to Avoid Injections: Preferences of Canadians with type 2 diabetes
Diabetes Care September 2005, Vol.28, 2243-2245. doi:https://doi.org/10.2337/diacare.28.9.2243
Emerging Treatments and Technologies
Autologous Transplantation of Granulocyte Colony–Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes
Pingping Huang, MD; Shangzhu Li, MSPH; Mingzhe Han, PHD; Zhijian Xiao, MD; Renchi Yang, MD; Zhong Chao Han, PHD, MD
Diabetes Care September 2005, Vol.28, 2155-2160. doi:https://doi.org/10.2337/diacare.28.9.2155
The Effect of Insulin Antibodies on the Metabolic Action of Inhaled and Subcutaneous Insulin: A prospective randomized pharmacodynamic study
Tim Heise, MD; Susanne Bott, MD; Corinna Tusek, MD; Jens-Armin Stephan, MD; Tom Kawabata, PHD; Deborah Finco-Kent, MS; Cameron Liu, PHD; Alan Krasner, MD
Diabetes Care September 2005, Vol.28, 2161-2169. doi:https://doi.org/10.2337/diacare.28.9.2161
Pathophysiology/Complications
The Role of Autoimmunity at Diagnosis of Type 1 Diabetes in the Development of Thyroid and Celiac Disease and Microvascular Complications
Sarah J. Glastras, MBBS (HONS), BSC PSYCHOL (HONS); Maria E. Craig, MBBS, PHD, FRACP; Charles F. Verge, MBBS, PHD, FRACP; Albert K. Chan, MAPPSTAT; Janine M. Cusumano, RN; Kim C. Donaghue, MBBS, PHD, FRACP
Diabetes Care September 2005, Vol.28, 2170-2175. doi:https://doi.org/10.2337/diacare.28.9.2170
Osteoprotegerin Is Associated With Silent Coronary Artery Disease in High-Risk but Asymptomatic Type 2 Diabetic Patients
Antoine Avignon, MD; Ariane Sultan, MD; Christophe Piot, MD; Stéphane Elaerts, MB; Jean Paul Cristol, MD; Anne Marie Dupuy, MD
Diabetes Care September 2005, Vol.28, 2176-2180. doi:https://doi.org/10.2337/diacare.28.9.2176
Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo
Jochen G. Schneider, MD; Maximilian von Eynatten, MD; Stephan Schiekofer, MD; Peter P. Nawroth, MD; Klaus A. Dugi, MD
Diabetes Care September 2005, Vol.28, 2181-2186. doi:https://doi.org/10.2337/diacare.28.9.2181
Hepatitis C Is a Predictor of Poorer Renal Survival in Diabetic Patients
Diabetes Care September 2005, Vol.28, 2187-2191. doi:https://doi.org/10.2337/diacare.28.9.2187
Monotonicity of Nerve Tests in Diabetes: Subclinical nerve dysfunction precedes diagnosis of polyneuropathy
Peter J. Dyck, MD; Peter C. O’Brien, PHD; William J. Litchy, MD; C. Michel Harper, MD; Christopher J. Klein, MD; P. James B. Dyck, MD
Diabetes Care September 2005, Vol.28, 2192-2200. doi:https://doi.org/10.2337/diacare.28.9.2192
Back to Basics in Diagnosing Diabetic Polyneuropathy With the Tuning Fork!
Jan-Willem G. Meijer, MD, PHD; Andries J. Smit, MD, PHD; Joop D. Lefrandt, MD; Johannes H. van der Hoeven, MD, PHD; Klaas Hoogenberg, MD, PHD; Thera P. Links, MD, PHD
Diabetes Care September 2005, Vol.28, 2201-2205. doi:https://doi.org/10.2337/diacare.28.9.2201
An Evaluation of the Efficacy of Methods Used in Screening for Lower-Limb Arterial Disease in Diabetes
Diabetes Care September 2005, Vol.28, 2206-2210. doi:https://doi.org/10.2337/diacare.28.9.2206
Female Advantage in AMI Mortality Is Reversed in Patients With Type 2 Diabetes in the Skaraborg Project
Charlotte A. Larsson, MSCPH; Bo Gullberg, PHD; Juan Merlo, MD, PHD; Lennart Rastam, MD, PHD; Ulf Lindblad, MD, PHD
Diabetes Care September 2005, Vol.28, 2246-2248. doi:https://doi.org/10.2337/diacare.28.9.2246
Erythropoietin Is Highly Elevated in Vitreous Fluid of Patients With Proliferative Diabetic Retinopathy
Yoshiya Katsura, MD; Tadashi Okano, MD; Kazuhisa Matsuno, MD; Masahiro Osako, MD; Masahiko Kure, DM; Toshiya Watanabe, MD; Yoshiki Iwaki, MD; Masayuki Noritake, MD; Hiroshi Kosano, PHD; Hideo Nishigori, PHD; Takeshi Matsuoka, MD
Diabetes Care September 2005, Vol.28, 2252-2254. doi:https://doi.org/10.2337/diacare.28.9.2252
Electrocardiographic Left Ventricular Hypertrophy in Type 1 Diabetes: Prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study
Sara Giunti, MD; Graziella Bruno, MD; Massimo Veglio, MD; Gabriella Gruden, MD, PHD; David J. Webb, MSC; Shona Livingstone, MSC; Nish Chaturvedi, MRCP, MD; John H. Fuller, FRCP; Paolo Cavallo Perin, MD; the EURODIAB IDDM Complications Study Group
Diabetes Care September 2005, Vol.28, 2255-2257. doi:https://doi.org/10.2337/diacare.28.9.2255
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes
Metabolic Syndrome Accompanied by Hypercholesterolemia Is Strongly Associated With Proinflammatory State and Impairment of Fibrinolysis in Patients With Type 2 Diabetes: Synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor
Yoshimasa Aso, MD; Sadao Wakabayashi, MD; Ruriko Yamamoto, MD; Rika Matsutomo, MD; Kohzo Takebayashi, MD; Toshihiko Inukai, MD
Diabetes Care September 2005, Vol.28, 2211-2216. doi:https://doi.org/10.2337/diacare.28.9.2211
Quantitative Coronary Angiographic Studies of Patients With Angina Pectoris and Impaired Glucose Tolerance
Yu Kataoka, MD; Satoshi Yasuda, MD; Isao Morii, MD; Yoritaka Otsuka, MD; Atsushi Kawamura, MD; Shunichi Miyazaki, MD
Diabetes Care September 2005, Vol.28, 2217-2222. doi:https://doi.org/10.2337/diacare.28.9.2217
Higher Medical Care Costs Accompany Impaired Fasting Glucose
Diabetes Care September 2005, Vol.28, 2223-2229. doi:https://doi.org/10.2337/diacare.28.9.2223
Alcohol Intake Among Women and Its Relationship to Diabetes Incidence and All-Cause Mortality: The 32-year follow-up of a population study of women in Gothenburg, Sweden
Leif Lapidus, MD; Calle Bengtsson; Elisabet Bergfors, MD; Cecilia Björkelund; Fredrik Spak; Lauren Lissner
Diabetes Care September 2005, Vol.28, 2230-2235. doi:https://doi.org/10.2337/diacare.28.9.2230
Increased Mortality Associated With the Metabolic Syndrome in Older Women With Diabetes
Teresa A. Hillier, MD; Joanne H. Rizzo, MA; Kathryn L. Pedula, MS; Jane A. Cauley, DRPH; Ann V. Schwartz, PHD; Kristine E. Ensrud, MD; Warren S. Browner, MD
Diabetes Care September 2005, Vol.28, 2258-2260. doi:https://doi.org/10.2337/diacare.28.9.2258
Reviews/Commentaries/ADA Statements
The Impact of ACE Inhibitors or Angiotensin II Type 1 Receptor Blockers on the Development of New-Onset Type 2 Diabetes
Effie L. Gillespie, PHARMD; C. Michael White, PHARMD; Michael Kardas, PHARMD; Michael Lindberg, MD; Craig I. Coleman, PHARMD
Diabetes Care September 2005, Vol.28, 2261-2266. doi:https://doi.org/10.2337/diacare.28.9.2261
Enteral Nutritional Support and Use of Diabetes-Specific Formulas for Patients With Diabetes: A systematic review and meta-analysis
Marinos Elia, MD, BSC(HONS), FRCP; Antonio Ceriello, MD; Heiner Laube, MD, PHD; Alan J. Sinclair, MD, PHD; Meike Engfer, PHD; Rebecca J. Stratton, BSC(HONS), PHD, SRD
Diabetes Care September 2005, Vol.28, 2267-2279. doi:https://doi.org/10.2337/diacare.28.9.2267
Ethnic Differences in Mortality, End-Stage Complications, and Quality of Care Among Diabetic Patients: A review
Loes C. Lanting, MSC; Inez M.A. Joung, PHD; Johan P. Mackenbach, PHD, MD; Steven W.J. Lamberts, PHD, MD; Aart H. Bootsma, PHD, MD
Diabetes Care September 2005, Vol.28, 2280-2288. doi:https://doi.org/10.2337/diacare.28.9.2280
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care September 2005, Vol.28, 2289-2304. doi:https://doi.org/10.2337/diacare.28.9.2289
Recommendations for Management of Diabetes During Ramadan
Monira Al-Arouj, MD; Radhia Bouguerra, MD; John Buse, MD, PHD; Sherif Hafez, MD, FACP; Mohamed Hassanein, FRCP; Mahmoud Ashraf Ibrahim, MD; Faramarz Ismail-Beigi, MD, PHD; Imad El-Kebbi, MD; Oussama Khatib, MD, PHD; Suhail Kishawi, MD; Abdulrazzaq Al-Madani, MD; Aly A. Mishal, MD, FACP; Masoud Al-Maskari, MD, PHD; Abdalla Ben Nakhi, MD; Khaled Al-Rubean, MD
Diabetes Care September 2005, Vol.28, 2305-2311. doi:https://doi.org/10.2337/diacare.28.9.2305
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Diabetes Care September 2005, Vol.28, 2312-2319. doi:https://doi.org/10.2337/diacare.28.9.2312
Editorials
Point: Visceral Adiposity Is Causally Related to Insulin Resistance
Diabetes Care September 2005, Vol.28, 2322-2325. doi:https://doi.org/10.2337/diacare.28.9.2322
Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance
Diabetes Care September 2005, Vol.28, 2326-2328. doi:https://doi.org/10.2337/diacare.28.9.2326
Letters: Observations
Burden of Type 2 Diabetes in Young Korean Adults Owing to Obesity
Diabetes Care September 2005, Vol.28, 2329. doi:https://doi.org/10.2337/diacare.28.9.2329
Thiazolidinediones and Lowered HDL Cholesterol
Diabetes Care September 2005, Vol.28, 2329-2330. doi:https://doi.org/10.2337/diacare.28.9.2329-a
Fulminant Autoantibody-Negative and Type 1A Diabetes Phenotypes in a Korean HLA Identical Dizygotic Twin
Jung H. Jung, MD; Jong R. Hahm, MD; Me A. Kim, MD; Myoung H. Park, MD; Deok R. Kim, PHD; Tae S. Jung, MD; Soon I. Chung, MD
Diabetes Care September 2005, Vol.28, 2330-2331. doi:https://doi.org/10.2337/diacare.28.9.2330
Forty-Year Observation of 280 Japanese Patients With Congenital Rubella Syndrome
Diabetes Care September 2005, Vol.28, 2331-2332. doi:https://doi.org/10.2337/diacare.28.9.2331
Intramyocellular Lipid Is Not Significantly Increased in Healthy Young Insulin Resistant First-Degree Relatives of Diabetic Subjects
Adamandia D. Kriketos, PHD; Gareth S. Denyer, PHD; Campbell H. Thompson, MD, DPHIL; Lesley V. Campbell, MBBS, FRACP
Diabetes Care September 2005, Vol.28, 2332-2333. doi:https://doi.org/10.2337/diacare.28.9.2332
Can Glargine Reduce the Number of Lung Infections in Patients With Cystic Fibrosis–Related Diabetes?
Adriana Franzese, MD; Maria Immacolata Spagnuolo, MD, PHD; Angela Sepe, MD; Giuliana Valerio, MD, PHD; Enza Mozzillo, MD; Valeria Raia, MD
Diabetes Care September 2005, Vol.28, 2333. doi:https://doi.org/10.2337/diacare.28.9.2333
Stockpiling of Ovarian Follicles and the Response to Rosiglitazone
Diabetes Care September 2005, Vol.28, 2333-2334. doi:https://doi.org/10.2337/diacare.28.9.2333-a
Detection of Associated Ocular Lesions During Screening of Diabetic Retinopathy
Nilanjana Deb-Joardar, MD, FRCSED; Natacha Germain, MD; Gilles Thuret, MD, PHD; Anne-Frédérique Garcin, MD; Pierre Manoli, MD; Bruno Estour, MD; Philippe Gain, MD, PHD
Diabetes Care September 2005, Vol.28, 2334-2335. doi:https://doi.org/10.2337/diacare.28.9.2334
Letters: Comments and Responses
Are Fatty Acids a Link Between Diabetes and Lowered Cognitive Performance?: Response to Brands et al.
Diabetes Care September 2005, Vol.28, 2335. doi:https://doi.org/10.2337/diacare.28.9.2335
Are Fatty Acids a Link Between Diabetes and Lowered Cognitive Performance?: Response to Ross
Augustina M.A. Brands, MSC; Geert Jan Biessels, PHD, MD; Edward H.F. de Haan, PHD; L. Jaap Kappelle, PHD, MD; Roy P.C. Kessels, PHD
Diabetes Care September 2005, Vol.28, 2335-2336. doi:https://doi.org/10.2337/diacare.28.9.2335-a
Eliminating Inpatient Sliding-Scale Insulin: A Reeducation Project With Medical House Staff: Response to Baldwin et al.
Diabetes Care September 2005, Vol.28, 2336. doi:https://doi.org/10.2337/diacare.28.9.2336
Eliminating Inpatient Sliding-Scale Insulin: A Reeducation Project With Medical House Staff: Response to Rizvi
Diabetes Care September 2005, Vol.28, 2336-2337. doi:https://doi.org/10.2337/diacare.28.9.2336-a
Errata
Errata
Diabetes Care September 2005, Vol.28, 2340-2341. doi:https://doi.org/10.2337/diacare.28.9.2340
